189 related articles for article (PubMed ID: 16134730)
1. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
[TBL] [Abstract][Full Text] [Related]
2. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.
Specks U; Fervenza FC; McDonald TJ; Hogan MC
Arthritis Rheum; 2001 Dec; 44(12):2836-40. PubMed ID: 11762944
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
[TBL] [Abstract][Full Text] [Related]
4. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
Eriksson P
J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
[TBL] [Abstract][Full Text] [Related]
5. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
[TBL] [Abstract][Full Text] [Related]
6. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab].
Minami R; Miyamura T; Watanabe H; Takahama S; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):133-8. PubMed ID: 17473516
[TBL] [Abstract][Full Text] [Related]
8. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for refractory Wegener's granulomatosis.
Antoniu SA
Expert Opin Investig Drugs; 2006 Sep; 15(9):1115-7. PubMed ID: 16916277
[TBL] [Abstract][Full Text] [Related]
10. Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.
Ferraro AJ; Smith SW; Neil D; Savage CO
Nephrol Dial Transplant; 2008 Sep; 23(9):3030-2. PubMed ID: 18586761
[TBL] [Abstract][Full Text] [Related]
11. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
Roccatello D; Baldovino S; Alpa M; Rossi D; Napoli F; Naretto C; Cavallo R; Giachino O
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
15. Rituximab induced remission in a patient with Wegener's granulomatosis.
Kallenbach M; Duan H; Ring T
Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
[TBL] [Abstract][Full Text] [Related]
16. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
[No Abstract] [Full Text] [Related]
17. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
Dalkilic E; Alkis N; Kamali S
Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
[TBL] [Abstract][Full Text] [Related]
18. Treatment of granulomatosis with polyangiitis (Wegener's).
Pagnoux C; Guillevin L
Expert Rev Clin Immunol; 2015 Mar; 11(3):339-48. PubMed ID: 25644677
[TBL] [Abstract][Full Text] [Related]
19. Renal & ocular targets for therapy in Wegener's granulomatosis.
Joshi L; Hamour S; Salama AD; Pusey CD; Lightman S; Taylor SR
Inflamm Allergy Drug Targets; 2009 Mar; 8(1):70-9. PubMed ID: 19275695
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]